-
-
-
-
-
-
-
Skye Bioscience (SKYE) Misses Q3 EPS by 32c
-
-
-
-
-
-
-
Skye Bioscience Reports First Quarter 2025 Results and Highlights Nimacimab Differentiation in Obesity
-
-
-
-
-
-
-
Skye Bioscience to Announce Third Quarter 2024 Results
-
-
-
1,198,550 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

